Novartis AG - NVS share price

About

Novartis AG, headquartered in Switzerland, is a leading pharmaceutical company that develops, manufactures, and markets a wide array of prescription drugs, active pharmaceutical ingredients (APIs), biosimilars, and ophthalmic products. With a focus on leveraging science and digital technologies, Novartis targets various disease areas including immunology, dermatology, oncology, ophthalmology, neuroscience, respiratory, cardiovascular, renal, and metabolism. The company operates through two primary segments:
Innovative Medicines: This division concentrates on the development and commercialization of innovative, patent-protected prescription medicines, particularly in areas such as blood pressure, cancer, and other critical diseases.
Sandoz: Sandoz specializes in generic pharmaceuticals and biosimilars, aiming to provide cost-effective alternatives to branded medications, thereby improving access to essential treatments globally.